Significance of Thymidylate Synthase and Thyroid Transcription Factor 1 Expression in Patients with Nonsquamous Non-small Cell Lung Cancer Treated with Pemetrexed-Based Chemotherapy (Q51443990)

From Wikidata

Jump to navigation Jump to search

scientific article published on August 1, 2011

Language	Label	Description	Also known as
English	Significance of Thymidylate Synthase and Thyroid Transcription Factor 1 Expression in Patients with Nonsquamous Non-small Cell Lung Cancer Treated with Pemetrexed-Based Chemotherapy	scientific article published on August 1, 2011

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/21716147

Significance of thymidylate synthase and thyroid transcription factor 1 expression in patients with nonsquamous non-small cell lung cancer treated with pemetrexed-based chemotherapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/21716147

Significance of Thymidylate Synthase and Thyroid Transcription Factor 1 Expression in Patients with Nonsquamous Non-small Cell Lung Cancer Treated with Pemetrexed-Based Chemotherapy (English)

1 reference

10.1097/JTO.0B013E3182208EA8

https://api.crossref.org/works/10.1097/JTO.0B013E3182208EA8

5 December 2024

0 references

1 reference

based on heuristic

inferred from title

non-small-cell lung carcinoma

1 reference

based on heuristic

inferred from title

author name string

Jong-Mu Sun

1

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/21716147

Joungho Han

2

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/21716147

Jin Seok Ahn

3

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/21716147

Keunchil Park

4

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/21716147

Myung-Ju Ahn

5

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/21716147

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21716147

5 December 2024

publication date

1 August 2011

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/21716147

August 2011

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21716147

5 December 2024

full work available at URL

http://www.jto.org/article/S1556086415310686/pdf

Portable Document Format

online access status

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21716147

5 December 2024

https://api.elsevier.com/content/article/PII:S1556086415310686?httpAccept=text/xml

1 reference

10.1097/JTO.0B013E3182208EA8

https://api.crossref.org/works/10.1097/JTO.0B013E3182208EA8

5 December 2024

https://api.elsevier.com/content/article/PII:S1556086415310686?httpAccept=text/plain

1 reference

10.1097/JTO.0B013E3182208EA8

https://api.crossref.org/works/10.1097/JTO.0B013E3182208EA8

5 December 2024

Journal of Thoracic Oncology

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/21716147

6

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/21716147

8

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/21716147

1392-1399

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/21716147

Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy

1

1 reference

10.1097/JTO.0B013E3182208EA8

https://api.crossref.org/works/10.1097/JTO.0B013E3182208EA8

5 December 2024

Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer

2

1 reference

10.1097/JTO.0B013E3182208EA8

https://api.crossref.org/works/10.1097/JTO.0B013E3182208EA8

5 December 2024

Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non-small-cell lung cancer: a randomised, double-blind, phase 3 study

3

1 reference

10.1097/JTO.0B013E3182208EA8

https://api.crossref.org/works/10.1097/JTO.0B013E3182208EA8

5 December 2024

Squamous cell carcinoma of the lung compared with other histotypes shows higher messenger RNA and protein levels for thymidylate synthase

4

1 reference

10.1097/JTO.0B013E3182208EA8

https://api.crossref.org/works/10.1097/JTO.0B013E3182208EA8

5 December 2024

Significance of thymidylate synthase for resistance to pemetrexed in lung cancer

5

1 reference

10.1097/JTO.0B013E3182208EA8

https://api.crossref.org/works/10.1097/JTO.0B013E3182208EA8

5 December 2024

Thyroid transcription factor-1 (TTF-1) expression in human lung carcinomas: its prognostic implication and relationship with wxpressions of p53 and Ki-67 proteins

6

1 reference

10.1097/JTO.0B013E3182208EA8

https://api.crossref.org/works/10.1097/JTO.0B013E3182208EA8

5 December 2024

Thyroid transcription factor-1 expression prevalence and its clinical implications in non-small cell lung cancer: a high-throughput tissue microarray and immunohistochemistry study.

7

1 reference

10.1097/JTO.0B013E3182208EA8

https://api.crossref.org/works/10.1097/JTO.0B013E3182208EA8

5 December 2024

Prognostic significance of thyroid transcription factor-1 expression in both early-stage conventional adenocarcinoma and bronchioloalveolar carcinoma of the lung

8

1 reference

10.1097/JTO.0B013E3182208EA8

https://api.crossref.org/works/10.1097/JTO.0B013E3182208EA8

5 December 2024

Prognostic value of thyroid transcription factor-1 in primary, resected, non-small cell lung carcinoma

9

1 reference

10.1097/JTO.0B013E3182208EA8

https://api.crossref.org/works/10.1097/JTO.0B013E3182208EA8

5 December 2024

Immunoreactivity for thyroid transcription factor-1 in stage I non-small cell carcinomas of the lung.

10

1 reference

10.1097/JTO.0B013E3182208EA8

https://api.crossref.org/works/10.1097/JTO.0B013E3182208EA8

5 December 2024

Prognostic relevance of TTF-1 and MMP-9 expression in advanced lung adenocarcinoma

11

1 reference

10.1097/JTO.0B013E3182208EA8

https://api.crossref.org/works/10.1097/JTO.0B013E3182208EA8

5 December 2024

Thyroid transcription factor 1--a new prognostic factor in lung cancer: a meta-analysis

12

1 reference

10.1097/JTO.0B013E3182208EA8

https://api.crossref.org/works/10.1097/JTO.0B013E3182208EA8

5 December 2024

Positive thyroid transcription factor 1 staining strongly correlates with survival of patients with adenocarcinoma of the lung

13

1 reference

10.1097/JTO.0B013E3182208EA8

https://api.crossref.org/works/10.1097/JTO.0B013E3182208EA8

5 December 2024

Thyroid transcription factor 1 is an independent prognostic factor for patients with stage I lung adenocarcinoma

14

1 reference

10.1097/JTO.0B013E3182208EA8

https://api.crossref.org/works/10.1097/JTO.0B013E3182208EA8

5 December 2024

Thyroid transcription factor-1 inhibits transforming growth factor-beta-mediated epithelial-to-mesenchymal transition in lung adenocarcinoma cells

15

1 reference

10.1097/JTO.0B013E3182208EA8

https://api.crossref.org/works/10.1097/JTO.0B013E3182208EA8

5 December 2024

Diversity of gene expression in adenocarcinoma of the lung

16

1 reference

10.1097/JTO.0B013E3182208EA8

https://api.crossref.org/works/10.1097/JTO.0B013E3182208EA8

5 December 2024

The differential efficacy of pemetrexed according to NSCLC histology: a review of two Phase III studies

18

1 reference

10.1097/JTO.0B013E3182208EA8

https://api.crossref.org/works/10.1097/JTO.0B013E3182208EA8

5 December 2024

Prognostic significance of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase protein expression in colorectal cancer patients treated with or without 5-fluorouracil-based chemotherapy

19

1 reference

10.1097/JTO.0B013E3182208EA8

https://api.crossref.org/works/10.1097/JTO.0B013E3182208EA8

5 December 2024

Thymidylate synthase expression in gastroenteropancreatic and pulmonary neuroendocrine tumors

20

1 reference

10.1097/JTO.0B013E3182208EA8

https://api.crossref.org/works/10.1097/JTO.0B013E3182208EA8

5 December 2024

Thymidylate synthase gene and protein expression correlate and are associated with response to 5-fluorouracil in human colorectal and gastric tumors

21

1 reference

10.1097/JTO.0B013E3182208EA8

https://api.crossref.org/works/10.1097/JTO.0B013E3182208EA8

5 December 2024

Comparison of thymidylate synthase (TS) protein up-regulation after exposure to TS inhibitors in normal and tumor cell lines and tissues

22

1 reference

10.1097/JTO.0B013E3182208EA8

https://api.crossref.org/works/10.1097/JTO.0B013E3182208EA8

5 December 2024

Fluorouracil and high-dose leucovorin in previously treated patients with metastatic breast cancer.

23

1 reference

10.1097/JTO.0B013E3182208EA8

https://api.crossref.org/works/10.1097/JTO.0B013E3182208EA8

5 December 2024

Immunohistochemical determination of thymidylate synthase in colorectal cancer--methodological studies

24

1 reference

10.1097/JTO.0B013E3182208EA8

https://api.crossref.org/works/10.1097/JTO.0B013E3182208EA8

5 December 2024

Prognostic role of thymidylate synthase, thymidine phosphorylase/platelet-derived endothelial cell growth factor, and proliferation markers in colorectal cancer

25

1 reference

10.1097/JTO.0B013E3182208EA8

https://api.crossref.org/works/10.1097/JTO.0B013E3182208EA8

5 December 2024

Differential Thymidylate Synthase Expression in Different Variants of Large-Cell Carcinoma of the Lung

26

1 reference

10.1097/JTO.0B013E3182208EA8

https://api.crossref.org/works/10.1097/JTO.0B013E3182208EA8

5 December 2024

Lung cancer heterogeneity: a blinded and randomized study of 100 consecutive cases

27

1 reference

10.1097/JTO.0B013E3182208EA8

https://api.crossref.org/works/10.1097/JTO.0B013E3182208EA8

5 December 2024

Cell type accuracy of bronchial biopsy specimens in primary lung cancer

28

1 reference

10.1097/JTO.0B013E3182208EA8

https://api.crossref.org/works/10.1097/JTO.0B013E3182208EA8

5 December 2024

High-grade neuroendocrine carcinoma of the lung shows increased thymidylate synthase expression compared to other histotypes

29

1 reference

10.1097/JTO.0B013E3182208EA8

https://api.crossref.org/works/10.1097/JTO.0B013E3182208EA8

5 December 2024

Identifiers

10.1097/JTO.0B013E3182208EA8

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/21716147

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/21716147

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51443990&oldid=2283907924"